Response to: ‘Riociguat in systemic sclerosis: a potential for disease modification’ by Jain and Dhir | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Correspondence response

Response to: ‘Riociguat in systemic sclerosis: a potential for disease modification’ by Jain and Dhir

Free

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

	Abstract	Full	Pdf
Jul 2020	456	454	85
Aug 2020	201	200	29
Sep 2020	46	40	10
Oct 2020	29	28	10
Nov 2020	24	21	8
Dec 2020	11	11	8
Jan 2021	14	14	8
Feb 2021	13	13	9
Mar 2021	9	9	8
Apr 2021	13	13	5
May 2021	51	55	6
Jun 2021	17	25	3
Jul 2021	27	35	1
Aug 2021	23	32	3
Sep 2021	16	26	5
Oct 2021	50	62	19
Nov 2021	30	38	12
Dec 2021	63	73	4
Jan 2022	30	39	2
Feb 2022	32	39	8
Mar 2022	25	34	1
Apr 2022	20	30	0
May 2022	34	41	10
Jun 2022	423	427	25
Jul 2022	131	139	15
Aug 2022	41	51	8
Sep 2022	36	41	23
Oct 2022	34	33	12
Nov 2022	28	29	11
Dec 2022	11	11	10
Jan 2023	42	42	13
Feb 2023	37	37	3
Mar 2023	9	9	6
Apr 2023	8	8	2
May 2023	24	24	7
Jun 2023	10	10	3
Jul 2023	2	2	4
Aug 2023	1	1	2
Sep 2023	23	23	3
Oct 2023	34	34	3
Nov 2023	12	12	8
Dec 2023	12	12	1
Jan 2024	16	14	2
Feb 2024	6	6	6
Mar 2024	5	4	51
Total	2179	2301	472